SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-000072
Filing Date
2023-01-06
Accepted
2023-01-06 08:30:44
Documents
12
Period of Report
2023-01-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K elev-20230105x8k.htm   iXBRL 8-K 60753
  Complete submission text file 0001558370-23-000072.txt   189882

Data Files

Seq Description Document Type Size
2 EX-101.SCH elev-20230105.xsd EX-101.SCH 3056
3 EX-101.LAB elev-20230105_lab.xml EX-101.LAB 16576
4 EX-101.PRE elev-20230105_pre.xml EX-101.PRE 10541
6 EXTRACTED XBRL INSTANCE DOCUMENT elev-20230105x8k_htm.xml XML 4998
Mailing Address 888 SEVENTH AVE 12TH FLOOR NEW YORK NY 10106
Business Address 888 SEVENTH AVE 12TH FLOOR NEW YORK NY 10106 212-651-6380
Elevation Oncology, Inc. (Filer) CIK: 0001783032 (see all company filings)

IRS No.: 841771427 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40523 | Film No.: 23513805
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences